Nagoya Protocol Sample Clauses

Nagoya Protocol. Hxxxxxx represents and warrants that, to Hxxxxxx’s *** Knowledge, to the extent applicable, the execution, delivery and performance of this Agreement by Roche and Hookipa complies with all obligations arising from and does not contravene any specific use restrictions of the United Nations’ Convention on Biological Diversity as entered into force on December 29, 1993 (CBD), the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity as entered into force on October 12, 2014, the Convention on International Trade in Endangered Species of Wild Fauna and Flora as entered into on March 3, 1973 (CITES) and all their implementing and other relevant national, local or indigenous access and benefit-sharing laws.
Sample 1
AutoNDA by SimpleDocs
Nagoya Protocol. In consideration of the provisions of the Convention on Biological Diversity and Nagoya Protocol of October 29, 2010 on the access to genetic resources and to any associated traditional knowledge, the research activities on the latter shall be authorized by the national competent authority of the provider country (or the community if applicable). The Provider shall confirm that he/she has been informed on the research project by the user and consents to provide access to genetic resources in situ and/or ex situ. An applicant for a permit to access biological resources for commercial purposes or potential commercial must enter into a benefit-sharing agreement with each access provider for the resources. In that context, [name] undertakes to obtain from the national competent authority and/or official provider, a permit to access to genetic resources in application of national law and international treaty. IRD undertake to use its best efforts to help for compiling the authorisation file and obtain the permit.
Sample 1

Related to Nagoya Protocol

  • Protocol The attached Protocol shall be an integral part of this Agreement.

  • Signaling protocol The Parties will interconnect their networks using SS7 signaling where Technically Feasible and available as defined in GR 905 Telcordia Standards including ISDN User Part (ISUP) for trunk signaling and TCAP for CCS-based features in the Interconnection of their networks. All Network Operations Forum (NOF) adopted standards shall be adhered to. Where available, CenturyLink signaling services to link its Signaling Transfer Points (STPs) for CLEC switches which connect to CenturyLink’s STPs via “A” links or for CLEC’s STPs to connect to CenturyLink’s STPs via “D” links which are dedicated to the transport of signaling for local Interconnection, may be ordered from the CenturyLink Tariff.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Review Protocol A narrative description of how the Claims Review was conducted and what was evaluated.

  • Technical Specifications 1. A procuring entity shall not prepare, adopt or apply any technical specification or prescribe any conformity assessment procedure with the purpose or effect of creating an unnecessary obstacle to trade between the Parties.

  • DRUG-FREE WORKPLACE FORM The Drug-Free Workplace Form is attached and shall be completed and submitted with your bid.

  • Data Encryption Contractor must encrypt all State data at rest and in transit, in compliance with FIPS Publication 140-2 or applicable law, regulation or rule, whichever is a higher standard. All encryption keys must be unique to State data. Contractor will secure and protect all encryption keys to State data. Encryption keys to State data will only be accessed by Contractor as necessary for performance of this Contract.

Time is Money Join Law Insider Premium to draft better contracts faster.